{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T21:27:39Z","timestamp":1748554059220,"version":"3.37.3"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"DOI":"10.1093\/eurjpc\/zwad150","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T03:09:00Z","timestamp":1683774540000},"page":"986-987","source":"Crossref","is-referenced-by-count":1,"title":["Is intensive blood pressure reduction a possible solution to counteract the development of diabetes mellitus?"],"prefix":"10.1093","volume":"30","author":[{"given":"Francesca","family":"Saladini","sequence":"first","affiliation":[{"name":"Cardiology Unit, Cittadella Town Hospital , Via Riva dell\u2019Ospedale 35013, Padova , Italy"},{"name":"Department of Medicine, University of Padova , Padova , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5402-4946","authenticated-orcid":false,"given":"Paolo","family":"Palatini","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Padova , Padova , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"2023080100353759100_zwad150-B1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"The SPRINT Research Group","year":"2015","journal-title":"N Engl J Med"},{"key":"2023080100353759100_zwad150-B2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"key":"2023080100353759100_zwad150-B3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/CIRCULATIONAHA.117.028441","article-title":"Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: SPRINT (systolic blood pressure intervention trial)","volume":"136","author":"Soliman","year":"2017","journal-title":"Circulation"},{"key":"2023080100353759100_zwad150-B4","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1161\/HYPERTENSIONAHA.122.20022","article-title":"Temporal relationship between arterial stiffness and systolic blood pressure under intensive or standard control: a post hoc analysis of the STEP trial","volume":"79","author":"Ling","year":"2022","journal-title":"Hypertension"},{"key":"2023080100353759100_zwad150-B5","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1042637","article-title":"Effects of intensive vs. standard blood pressure control on cognitive function: post-hoc analysis of the STEP randomized controlled trial","volume":"14","author":"Fan","year":"2023","journal-title":"Front Neurol"},{"key":"2023080100353759100_zwad150-B6","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/7533353","article-title":"Intensive blood pressure control and diabetes mellitus incidence for patients with impaired fasting glucose: a secondary analysis of SPRINT","volume":"2023","author":"Lin","year":"2023","journal-title":"Int J Hypertens"},{"key":"2023080100353759100_zwad150-B7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.118.12572","article-title":"Blood pressure control and the association with diabetes Mellitus incidence: results from SPRINT randomized trial","volume":"75","author":"Roumie","year":"2020","journal-title":"Hypertension"},{"key":"2023080100353759100_zwad150-B8","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/HJH.0000000000001276","article-title":"Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10\u2014should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials","volume":"35","author":"Thomopoulos","year":"2017","journal-title":"J Hypertens"},{"key":"2023080100353759100_zwad150-B9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/dom.14927","article-title":"Effects of intensive blood pressure lowering in patients with diabetes: a pooled analysis of the STEP and ACCORD-BP randomized trials","volume":"25","author":"Yang","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"2023080100353759100_zwad150-B10","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(21)01920-6","article-title":"Blood pressure lowering treatment trialists\u2019 collaboration. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis","volume":"398","author":"Nazarzadeh","year":"2021","journal-title":"Lancet"},{"key":"2023080100353759100_zwad150-B11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"2023080100353759100_zwad150-B12","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.291.16.1978","article-title":"Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus","volume":"291","author":"Meigs","year":"2004","journal-title":"JAMA"},{"key":"2023080100353759100_zwad150-B13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11892-004-0074-9","article-title":"Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes","volume":"4","author":"Caballero","year":"2004","journal-title":"Curr Diab Rep"},{"key":"2023080100353759100_zwad150-B14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/ajh.2011.113","article-title":"Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans","volume":"24","author":"Chamarthi","year":"2011","journal-title":"Am J Hypertens"},{"key":"2023080100353759100_zwad150-B15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","article-title":"Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms","volume":"34","author":"Petrie","year":"2018","journal-title":"Can J Cardiol"},{"key":"2023080100353759100_zwad150-B16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(12)60987-8","article-title":"Diabetes and hypertension: the bad companions","volume":"380","author":"Ferrannini","year":"2012","journal-title":"Lancet"},{"key":"2023080100353759100_zwad150-B17","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwad105","article-title":"Intensive blood pressure lowering and the risk of new-onset diabetes in patients with hypertension: a post-hoc analysis of the STEP randomized trial","volume":"30","author":"Yang","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"2023080100353759100_zwad150-B18","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and 446 country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"2023080100353759100_zwad150-B19","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2337\/diacare.28.9.2261","article-title":"The impact of 531 ACE inhibitors or angiotensin II type 1 receptor blockers on the development of 532 new-onset type 2 diabetes","volume":"28","author":"Gillespie","year":"2005","journal-title":"Diabetes Care"},{"key":"2023080100353759100_zwad150-B20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2005.05.051","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials","volume":"46","author":"Abuissa","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2023080100353759100_zwad150-B21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000125","article-title":"Antihypertensive drug class interactions and risk for incident diabetes: a nested case-control study","volume":"2","author":"Cooper-DeHoff","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2023080100353759100_zwad150-B22","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","author":"ALLHAT Collaborative Research Group","year":"2002","journal-title":"JAMA"},{"key":"2023080100353759100_zwad150-B23","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.amjcard.2007.05.057","article-title":"A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus","volume":"100","author":"Bangalore","year":"2007","journal-title":"Am J Cardiol"},{"key":"2023080100353759100_zwad150-B24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-126-12-199706150-00004","article-title":"Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial","volume":"126","author":"Giugliano","year":"1997","journal-title":"Ann Intern Med"},{"key":"2023080100353759100_zwad150-B25","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwad150\/50450048\/zwad150.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/30\/10\/986\/51012329\/zwad150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/30\/10\/986\/51012329\/zwad150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:36:20Z","timestamp":1690850180000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/30\/10\/986\/7158590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,5,9]]},"published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwad150","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"type":"print","value":"2047-4873"},{"type":"electronic","value":"2047-4881"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,5,9]]}}}